Category Archives: Regulatory Disclosures

Disclosure to EGX on BOD minutes

EGX Disclosure on BOD and shareholding structure

EGX disclosure regarding Rameda’s manufacturing of “Anviziram” Tablets the Generic Equivalent of Japanese antiviral Avigan for treatment of Covid-19 patients and receives approval from Egyptian Drug Authority to manufacture Remedsivir

Disclosure to EGX on BOD minutes

Rameda AGM Meeting Minutes – 10 May 2020

Summary of AGM Decisions – 10 May 2020

EGX disclosure regarding the upcoming AGM on 10 May 2020

EGX Disclosure regarding Rameda’s Governance Report

EGX Disclosure on BOD and shareholding structure

EGX Disclosure on BOD and shareholding structure